Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2007 1
2009 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Emerging therapies for multiple myeloma.
Podar K, Tai YT, Hideshima T, Vallet S, Richardson PG, Anderson KC. Podar K, et al. Expert Opin Emerg Drugs. 2009 Mar;14(1):99-127. doi: 10.1517/14728210802676278. Expert Opin Emerg Drugs. 2009. PMID: 19249983 Free PMC article. Review.
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications.
Podar K, Anderson KC. Podar K, et al. Blood. 2005 Feb 15;105(4):1383-95. doi: 10.1182/blood-2004-07-2909. Epub 2004 Oct 7. Blood. 2005. PMID: 15471951 Review.
Caveolin-1 as a potential new therapeutic target in multiple myeloma.
Podar K, Anderson KC. Podar K, et al. Cancer Lett. 2006 Feb 20;233(1):10-5. doi: 10.1016/j.canlet.2005.02.035. Cancer Lett. 2006. PMID: 16473666 Review.
The therapeutic role of targeting protein kinase C in solid and hematologic malignancies.
Podar K, Raab MS, Chauhan D, Anderson KC. Podar K, et al. Expert Opin Investig Drugs. 2007 Oct;16(10):1693-707. doi: 10.1517/13543784.16.10.1693. Expert Opin Investig Drugs. 2007. PMID: 17922632 Review.